Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis

被引:27
|
作者
Wang, Long
Li, Mian
Zhao, Zhiyun
Xu, Min
Lu, Jieli
Wang, Tiange
Chen, Yuhong
Wang, Shuangyuan
Dai, Meng
Hou, Yanan
Wu, Xueyan
Ma, Lina
Li, Lin
Liu, Shanshan
Wang, Weiqing
Xu, Yu
Bi, Yufang
Ning, Guang
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Endocrine & Metab Dis, Natl Clin Res Ctr Metab Dis,Rui Jin Hosp, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai, Peoples R China
来源
AMERICAN JOURNAL OF MEDICINE | 2018年 / 131卷 / 12期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Cardiovascular health; Cohori; Nonalcoholic fatty liver disease; Prevention; FIBROSIS SCORE; NAFLD; RISK; PREVALENCE; MORTALITY; PREDICTOR;
D O I
10.1016/j.amjmed.2018.07.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Cardiovascular health has been proven to be associated with major cardiometabolic diseases. However, little is known of associations between cardiovascular health and nonalcoholic fatty liver disease. METHODS: This study included 3424 adults aged >= 40 years who were free of nonalcoholic fatty liver disease at baseline from a community cohort followed for up to 5 years. Liver ultrasonography was conducted at baseline and at follow-up to diagnose incident nonalcoholic fatty liver disease. Six metrics including smoking, physical activity, body mass index, total cholesterol, blood pressure, and fasting glucose were used to define cardiovascular health status. Associations of individual cardiovascular health metrics, number of cardiovascular health metrics, and overall cardiovascular health status at baseline, as well as changes in cardiovascular health during follow-up with risks of developing nonalcoholic fatty liver disease, were examined. RESULTS: A total of 649 participants developed nonalcoholic fatty liver disease during follow-up. Risks of nonalcoholic fatty liver disease reduced in a dose response manner in participants with 3-4 ideal cardiovascular health metrics (odds ratio 0.50; 95% confidence interval, 0.41-0.61) and in participants with 5-6 ideal metrics (odds ratio 0.34; 95% confidence interval 0.22-0.51) compared with participants with 0-2 ideal metrics. An overall ideal or intermediate cardiovascular health was associated with 37% reduction in developing nonalcoholic fatty liver disease compared with poor cardiovascular health. In addition, improving cardiovascular health during follow-up reduced the risk by 71% compared with deteriorating cardiovascular health. Furthermore, an overall ideal or intermediate cardiovascular health was significantly associated with a lower fibrosis score in nonalcoholic fatty liver disease patients compared with an overall poor cardiovascular health. CONCLUSIONS: Ideal cardiovascular health was inversely associated with risks of nonalcoholic fatty liver disease. Although treatment of nonalcoholic fatty liver disease and subsequent inflammation and fibrosis remains a challenge, cardiovascular health goals should be advocated for nonalcoholic fatty liver disease prevention. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1515.e1 / 1515.e10
页数:10
相关论文
共 50 条
  • [21] The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
    Yayla, Cagri
    Yayla, Kadriye Gayretli
    Karanfil, Mustafa
    Ertem, Ahmet Goktug
    Unal, Sefa
    Erdol, Mehmet Akif
    Demirtas, Koray
    Akdi, Ahmet
    Coteli, Cem
    Ozilhan, Murat Oguz
    Karaaslan, Ozge Cakmak
    ANGIOLOGY, 2020, 71 (01) : 87 - 87
  • [22] Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
    Bisaccia, Giandomenico
    Ricci, Fabrizio
    Mantini, Cesare
    Tana, Claudio
    Romani, Gian Luca
    Schiavone, Cosima
    Gallina, Sabina
    SAGE OPEN MEDICINE, 2020, 8
  • [23] Nonalcoholic fatty liver disease and cardiovascular disease risk
    Schindhelm R.K.
    Diamant M.
    Heine R.J.
    Current Diabetes Reports, 2007, 7 (3) : 181 - 187
  • [24] Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Risk
    Brown, Todd M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (06) : 568 - 569
  • [25] Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study
    van Kleef, Laurens A.
    Hofman, Amy
    Voortman, Trudy
    de Knegt, Robert J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (02): : 311 - 318
  • [26] Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease
    Ivancovsky-Wajcman, Dana
    Fliss-Isakov, Naomi
    Salomone, Federico
    Webb, Muriel
    Shibolet, Oren
    Kariv, Revital
    Zelber-Sagi, Shira
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (12) : 1698 - 1705
  • [27] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [28] Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease
    Targher, Giovanni
    Day, Christopher P.
    HEPATOLOGY, 2011, 53 (01) : 375 - 375
  • [29] Nonalcoholic Fatty Liver Disease and Cardiovascular Mortality in Older Individuals: A Prospective Cohort Study
    Mahady, Suzanne E.
    Wong, Germaine
    Turner, Robin M.
    Mitchell, Paul
    Macaskill, Petra
    Craig, Jonathan
    George, Jacob
    GASTROENTEROLOGY, 2015, 148 (04) : S1048 - S1048
  • [30] Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease
    Du, Jing
    Pan, Xiaoping
    Lu, Zhigang
    Gao, Meifang
    Hu, Xiang
    Zhang, Xueli
    Bao, Yuqian
    Jia, Weiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21435 - 21441